Published in Gene Therapy Weekly, July 8th, 2004
The study also showed that the Oncotype DX Breast Cancer Assay Recurrence Score significantly correlated with response to chemotherapy in breast cancer patients. These results were presented at the annual meeting of the American Society of Clinical Oncology.
"We are encouraged by these early findings," said Luca Gianni, MD, Istituto Nazionale Tumori....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.